These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16958594)

  • 41. The story of PON1: how an organophosphate-hydrolysing enzyme is becoming a player in cardiovascular medicine.
    van Himbergen TM; van Tits LJ; Roest M; Stalenhoef AF
    Neth J Med; 2006 Feb; 64(2):34-8. PubMed ID: 16517986
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HDL-associated paraoxonase-1 can redistribute to cell membranes and influence sensitivity to oxidative stress.
    Deakin SP; Bioletto S; Bochaton-Piallat ML; James RW
    Free Radic Biol Med; 2011 Jan; 50(1):102-9. PubMed ID: 20850524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Paraoxonase 1 and HDL maturation.
    Gugliucci A; Menini T
    Clin Chim Acta; 2015 Jan; 439():5-13. PubMed ID: 25261854
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atherosclerosis: cell biology and lipoproteins--inflammation and oxidative stress in atherogenesis: protective role for paraoxonases.
    Aviram M
    Curr Opin Lipidol; 2011 Jun; 22(3):243-4. PubMed ID: 21562389
    [No Abstract]   [Full Text] [Related]  

  • 45. S-Glutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity.
    Rozenberg O; Aviram M
    Biochem Biophys Res Commun; 2006 Dec; 351(2):492-8. PubMed ID: 17070779
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action.
    Nguyen SD; Sok DE
    Free Radic Res; 2003 Dec; 37(12):1319-30. PubMed ID: 14753756
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Paraoxonases: ancient substrate hunters and their evolving role in ischemic heart disease.
    Martinelli N; Consoli L; Girelli D; Grison E; Corrocher R; Olivieri O
    Adv Clin Chem; 2013; 59():65-100. PubMed ID: 23461133
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Paraoxonase 1, atherosclerosis and arterial stiffness in renal patients.
    Gungor O; Kircelli F; Toz H
    Int Urol Nephrol; 2013 Apr; 45(2):441-7. PubMed ID: 22669508
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the impacts of antibiotic drugs on PON 1; a major bioscavenger against cardiovascular diseases.
    Ekinci D; Beydemir S
    Eur J Pharmacol; 2009 Sep; 617(1-3):84-9. PubMed ID: 19577563
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Active Site Hydrophobicity and the Convergent Evolution of Paraoxonase Activity in Structurally Divergent Enzymes: The Case of Serum Paraoxonase 1.
    Blaha-Nelson D; Krüger DM; Szeler K; Ben-David M; Kamerlin SC
    J Am Chem Soc; 2017 Jan; 139(3):1155-1167. PubMed ID: 28026940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of 3,4-dihydroxyphenylalanine on Cu(2+)-induced inactivation of HDL-associated paraoxonasel and oxidation of HDL; inactivation of paraoxonasel activity independent of HDL lipid oxidation.
    Nguyen SD; Sok DE
    Free Radic Res; 2004 Sep; 38(9):969-76. PubMed ID: 15621715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite.
    Connelly PW; Draganov D; Maguire GF
    Free Radic Biol Med; 2005 Jan; 38(2):164-74. PubMed ID: 15607900
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methylmercury-induced inhibition of paraoxonase-1 (PON1)-implications for cardiovascular risk.
    Ginsberg G; Sonawane B; Nath R; Lewandowski P
    J Toxicol Environ Health A; 2014; 77(17):1004-23. PubMed ID: 25072822
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HDL-paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects.
    Ferretti G; Bacchetti T; Masciangelo S; Bicchiega V
    Obesity (Silver Spring); 2010 Jun; 18(6):1079-84. PubMed ID: 19834469
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulating reconstituted high density lipoprotein functionality to target the Pseudomonas aeruginosa quorum sensing system.
    Deakin SP; Ducret V; Bioletto S; Perron K; James RW
    Life Sci; 2014 Sep; 112(1-2):68-73. PubMed ID: 25086378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the ability of paraoxonases 1 and 3 to attenuate the in vitro oxidation of low-density lipoprotein and reduce macrophage oxidative stress.
    Liu Y; Mackness B; Mackness M
    Free Radic Biol Med; 2008 Sep; 45(6):743-8. PubMed ID: 18585453
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Paraoxonase 1 activities, regulation, and interactions with atherosclerotic lesion.
    Aviram M; Vaya J
    Curr Opin Lipidol; 2013 Aug; 24(4):339-44. PubMed ID: 23508039
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The anti-inflammatory effect of paraoxonase 1 against oxidized lipids depends on its association with high density lipoproteins.
    Loued S; Isabelle M; Berrougui H; Khalil A
    Life Sci; 2012 Jan; 90(1-2):82-8. PubMed ID: 22067439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Purification and characterization of paraoxonase 1 (PON1) from Swiss Black, Holstein, and Montofon bovines.
    Erzengin M; Demir D; Arslan M; Sinan S
    Appl Biochem Biotechnol; 2014 Aug; 173(7):1597-606. PubMed ID: 24907040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.